Clinical Inquiries: Does niacin decrease cardiovascular morbidity and mortality in CVD patients?

Peter Lazzopina, Anne Mounsey, Lara Handler

Journal: The Journal of family practice 2019;67(5):314-316

PMID: 29726857

Abstract

No. Niacin doesn't reduce cardiovascular disease (CVD) morbidity or mortality in patients with established disease (strength of recommendation [SOR]: A, meta-analyses of randomized controlled trials [RCTs] and subsequent large RCTs). Niacin may be considered as monotherapy for patients intolerant of statins (SOR: B, one well-done RCT).

Address: University of North Carolina Family Medicine Residency, Chapel Hill, USA.; University of North Carolina, Chapel Hill, USA.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.